» Authors » M Assenmacher

M Assenmacher

Explore the profile of M Assenmacher including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 988
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Solderer A, Hicklin S, Assenmacher M, Ender A, Schmidlin P
Clin Oral Investig . 2024 May; 28(6):313. PMID: 38748295
Objectives: This randomized clinical trial focused on patients with thin peri-implant soft-tissue height (STH) (≤ 2.5 mm) and investigated the impact of an allogenic collagen scaffold (aCS) on supracrestal tissue...
2.
Kaiser A, Assenmacher M, Schroder B, Meyer M, Orentas R, Bethke U, et al.
Cancer Gene Ther . 2015 Jan; 22(2):72-8. PMID: 25613483
The recent successes of adoptive T-cell immunotherapy for the treatment of hematologic malignancies have highlighted the need for manufacturing processes that are robust and scalable for product commercialization. Here we...
3.
Bacher P, Kniemeyer O, Schonbrunn A, Sawitzki B, Assenmacher M, Rietschel E, et al.
Mucosal Immunol . 2013 Dec; 7(4):916-28. PMID: 24301658
Foxp3(+) regulatory T cells (Treg) have a central role for keeping the balance between pro- and anti-inflammatory immune responses against chronically encountered antigens at mucosal sites. However, their antigen specificity...
4.
Campbell J, Foerster A, Lasmanowicz V, Niemoller M, Scheffold A, Fahrendorff M, et al.
Clin Exp Immunol . 2010 Oct; 163(1):1-10. PMID: 20964638
T cell lines with defined cytokine profiles are an invaluable tool for assessing the control of immune responses both in vitro and in vivo. Production of such cell lines can...
5.
Horst A, Hunzelmann N, Arce S, Herber M, Manz R, Radbruch A, et al.
Clin Exp Immunol . 2002 Nov; 130(3):370-8. PMID: 12452825
In atopic patients and patients with hyper-IgE syndrome (HIE) highly elevated IgE serum levels can be detected. Due to their very low frequency little is known about IgE-producing plasma cells...
6.
Keenan R, Ainsworth J, Khan N, Bruton R, Cobbold M, Assenmacher M, et al.
Br J Haematol . 2001 Nov; 115(2):428-34. PMID: 11703346
Cytomegalovirus (CMV) reactivation and disease remains an important clinical problem for patients after allogeneic stem cell transplantation. Impaired cellular immune control of viral replication is responsible for viral reactivation, and...
7.
Becker C, Pohla H, Frankenberger B, Schuler T, Assenmacher M, Schendel D, et al.
Nat Med . 2001 Oct; 7(10):1159-62. PMID: 11590442
Successful adoptive T-cell therapy has been demonstrated in viral disease and selected forms of cancer. However, it is limited by the difficulty to efficiently isolate and amplify autologous tumor-reactive T-cell...
8.
Pittet M, Zippelius A, Speiser D, Assenmacher M, Guillaume P, Valmori D, et al.
J Immunol . 2001 Jun; 166(12):7634-40. PMID: 11390521
To elucidate the functional heterogeneity of Ag-specific T lymphocyte populations, we combined labeling of lymphocytes with MHC/peptide tetramers and a cell surface affinity matrix for IFN-gamma. Magnetic cell sorting of...
9.
Farrar J, Ouyang W, Lohning M, Assenmacher M, Radbruch A, Kanagawa O, et al.
J Exp Med . 2001 Mar; 193(5):643-50. PMID: 11238595
Although interleukin (IL)-12 and IL-4 polarize naive CD4(+) T cells toward T helper cell type 1 (Th1) or Th2 phenotypes, it is not known whether cytokines instruct the developmental fate...
10.
Hu-Li J, Pannetier C, Guo L, Lohning M, Gu H, Watson C, et al.
Immunity . 2001 Feb; 14(1):1-11. PMID: 11163225
CD4 cells from mice heterozygous for an IL-4 and a GFP/IL-4 gene frequently express a single allele. Analysis of IL-4 or GFP production by cells from recently primed Th2 cells...